| Literature DB >> 24589977 |
Guillaume Bergthold1, Pratiti Bandopadhayay2, Wenya Linda Bi1, Lori Ramkissoon3, Charles Stiles1, Rosalind A Segal4, Rameen Beroukhim1, Keith L Ligon3, Jacques Grill5, Mark W Kieran6.
Abstract
Low-grade gliomas represent the most frequent brain tumors arising during childhood. They are characterized by a broad and heterogeneous group of tumors that are currently classified by the WHO according to their morphological appearance. Here we review the clinical features of these tumors, current therapeutic strategies and the recent discovery of genomic alterations characteristic to these tumors. We further explore how these recent biological findings stand to transform the treatment for these tumors and impact the diagnostic criteria for pediatric low-grade gliomas.Entities:
Keywords: BRAF; Genetics; Low-grade glioma; Pediatric
Mesh:
Year: 2014 PMID: 24589977 PMCID: PMC4082403 DOI: 10.1016/j.bbcan.2014.02.004
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002